Advertisement

Nine months after Nabsys Inc. first said that it’s “initiating its transition from technology development to product commercialization,” CEO Barrett Bready is still quiet about when he plans to launch the life science company’s first product, a solid-state gene sequencing instrument.

Advertisement
Advertisement